Ensysce Biosciences (ENSC) Misses Q2 EPS by 79c
Tweet
Share
E-mailGet Alerts ENSC Hot Sheet
Join SI Premium – FREE
Ensysce Biosciences (NASDAQ: ENSC) reported Q2 EPS of ($0.79). Revenue for the quarter came in at $1.37 million.
For earnings history and earnings-related data on Ensysce Biosciences (ENSC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- Bogota Financial Corp. (BSBK) Reports Q2 EPS of $0.06
- Kotak Downgrades Dixon Technologies India Ltd (DIXON:IN) to Add (2)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
